# Tyson Foods, Inc.: overview

TSN · NYSE · CIK 100493 · [Consumer staples](/sectors/consumer-staples.md) · fiscal year ends Oct 3

Pages: [Overview](/companies/tsn.md) · [Financials](/companies/tsn/financials.md) · [Filings](/companies/tsn/filings.md) · [Insiders](/companies/tsn/insiders.md)

Latest reported revenue: [$13.87bn](/filings/0000100493-26-000058.md) for Q3 FY2026, three months to 2026-06-27, from the 10-Q filed Aug 3, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, accession 0000100493-26-000058).

## Last eight quarters

| Line item | Unit | Q4 FY2024 (2024-09-28) | Q1 FY2025 (2024-12-28) | Q2 FY2025 (2025-03-29) | Q3 FY2025 (2025-06-28) | Q4 FY2025 (2025-09-27) | Q1 FY2026 (2025-12-27) | Q2 FY2026 (2026-03-28) | Q3 FY2026 (2026-06-27) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $bn | [13.6 d](/filings/0000100493-25-000095.md) | [13.6](/filings/0000100493-26-000007.md) | [13.1](/filings/0000100493-26-000020.md) | [13.9](/filings/0000100493-26-000058.md) | [13.9 d](/filings/0000100493-25-000095.md) | [14.3](/filings/0000100493-26-000007.md) | [13.7](/filings/0000100493-26-000020.md) | [13.9](/filings/0000100493-26-000058.md) |
| Gross margin | % | [7.8% d](/filings/0000100493-25-000095.md) | [8.0%](/filings/0000100493-26-000007.md) | [4.6%](/filings/0000100493-26-000020.md) | [8.2%](/filings/0000100493-26-000058.md) | [5.2% d](/filings/0000100493-25-000095.md) | [5.6%](/filings/0000100493-26-000007.md) | [7.0%](/filings/0000100493-26-000020.md) | [6.6%](/filings/0000100493-26-000058.md) |
| Operating margin | % | [3.9% d](/filings/0000100493-25-000095.md) | [4.3%](/filings/0000100493-26-000007.md) | [0.8%](/filings/0000100493-26-000020.md) | [1.9%](/filings/0000100493-26-000058.md) | [1.1% d](/filings/0000100493-25-000095.md) | [2.1%](/filings/0000100493-26-000007.md) | [3.2%](/filings/0000100493-26-000020.md) | [2.6%](/filings/0000100493-26-000058.md) |
| Net margin | % | [2.6% d](/filings/0000100493-25-000095.md) | [2.6%](/filings/0000100493-26-000007.md) | [0.1%](/filings/0000100493-26-000020.md) | [0.4%](/filings/0000100493-26-000058.md) | [0.3% d](/filings/0000100493-25-000095.md) | [0.6%](/filings/0000100493-26-000007.md) | [1.9%](/filings/0000100493-26-000020.md) | [1.3%](/filings/0000100493-26-000058.md) |
| Diluted EPS | $ per share | not reported | [1.01](/filings/0000100493-26-000007.md) | [0.02](/filings/0000100493-26-000020.md) | [0.17](/filings/0000100493-26-000058.md) | not reported | [0.24](/filings/0000100493-26-000007.md) | [0.73](/filings/0000100493-26-000020.md) | [0.52](/filings/0000100493-26-000058.md) |
| Free cash flow | $bn | [0.4 d](/filings/0000100493-25-000095.md) | [0.8](/filings/0000100493-26-000007.md) | [(0.4) d](/filings/0000100493-26-000020.md) | [0.5 d](/filings/0000100493-26-000058.md) | [0.2 d](/filings/0000100493-25-000095.md) | [0.7](/filings/0000100493-26-000007.md) | [(0.3) d](/filings/0000100493-26-000020.md) | [0.5 d](/filings/0000100493-26-000058.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 12-month figure less the 9-month figure; 6-month figure less the 3-month figure; 9-month figure less the 6-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-10-02) | FY2022 (2022-10-01) | FY2023 (2023-09-30) | FY2024 (2024-09-28) | FY2025 (2025-09-27) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $bn | [47.0](/filings/0000100493-23-000105.md) | [53.3](/filings/0000100493-24-000119.md) | [52.9](/filings/0000100493-25-000095.md) | [53.3](/filings/0000100493-25-000095.md) | [54.4](/filings/0000100493-25-000095.md) |
| Gross margin | % | [13.9%](/filings/0000100493-23-000105.md) | [12.5%](/filings/0000100493-24-000119.md) | [5.0%](/filings/0000100493-25-000095.md) | [6.8%](/filings/0000100493-25-000095.md) | [6.5%](/filings/0000100493-25-000095.md) |
| Operating margin | % | [9.3%](/filings/0000100493-23-000105.md) | [8.3%](/filings/0000100493-24-000119.md) | [(0.7%)](/filings/0000100493-25-000095.md) | [2.6%](/filings/0000100493-25-000095.md) | [2.0%](/filings/0000100493-25-000095.md) |
| Net margin | % | [6.5%](/filings/0000100493-23-000105.md) | [6.1%](/filings/0000100493-24-000119.md) | [(1.2%)](/filings/0000100493-25-000095.md) | [1.5%](/filings/0000100493-25-000095.md) | [0.9%](/filings/0000100493-25-000095.md) |
| Diluted EPS | $ per share | [8.34](/filings/0000100493-23-000105.md) | [8.92](/filings/0000100493-24-000119.md) | [(1.87)](/filings/0000100493-25-000095.md) | [2.25](/filings/0000100493-25-000095.md) | [1.33](/filings/0000100493-25-000095.md) |
| Free cash flow | $bn | [2.6](/filings/0000100493-23-000105.md) | [0.8](/filings/0000100493-24-000119.md) | [(0.2)](/filings/0000100493-25-000095.md) | [1.5](/filings/0000100493-25-000095.md) | [1.2](/filings/0000100493-25-000095.md) |

- Revenue. XBRL Revenue: us-gaap:Revenues; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:Revenues; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/tsn/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $1.50bn | 26,216,957 |  | Added +1,328,886 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $1.06bn | 18,433,920 |  | Added +117,273 |
| [PZENA INVESTMENT MANAGEMENT LLC](/funds/1027796.md) | 2026-06-30 | $974.2m | 17,016,651 |  | Reduced −139,062 |
| [VANGUARD PORTFOLIO MANAGEMENT LLC](/funds/2100121.md) | 2026-06-30 | $889.0m | 15,528,970 |  | Added +110,980 |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $839.4m | 14,661,388 |  | Added +342,190 |
| [Davis Selected Advisers](/funds/1036325.md) | 2026-06-30 | $724.5m | 12,653,717 |  | Reduced −436,972 |
| [AQR CAPITAL MANAGEMENT LLC](/funds/1167557.md) | 2026-06-30 | $469.3m | 8,197,389 |  | Reduced −1,796,079 |
| [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $440.4m | 7,722,169 |  | Added +103,920 |
| [Invesco Ltd.](/funds/914208.md) | 2026-06-30 | $316.4m | 5,526,193 |  | Reduced −660,204 |
| [NORTHERN TRUST CORP](/funds/73124.md) | 2026-06-30 | $275.1m | 4,805,540 |  | Reduced −325,277 |

## Recent filings

[All 1,385 filings](/companies/tsn/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-09-03 | 09:13 ET | [8-K](/filings/0000100493-26-000067.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000100493-26-000067 |
| 2026-08-24 | 16:47 ET | [8-K](/filings/0001140361-26-034204.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-26-034204 |
| 2026-08-24 | 16:21 ET | [8-K](/filings/0001140361-26-034195.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-26-034195 |
| 2026-08-13 | 16:29 ET | [8-K](/filings/0000100493-26-000063.md) | 7.01 Regulation FD disclosure | 0000100493-26-000063 |
| 2026-08-11 | 21:55 ET | [8-K](/filings/0001140361-26-032111.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-26-032111 |
| 2026-08-10 | 09:01 ET | [8-K](/filings/0001140361-26-031947.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-26-031947 |
| 2026-08-03 | 07:39 ET | [10-Q](/filings/0000100493-26-000058.md) | Quarterly report, period 2026-06-27 | 0000100493-26-000058 |
| 2026-08-03 | 07:37 ET | [8-K](/filings/0000100493-26-000057.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000100493-26-000057 |
| 2026-06-18 | 16:38 ET | [8-K](/filings/0000100493-26-000050.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000100493-26-000050 |
| 2026-06-17 | 17:12 ET | [8-K/A](/filings/0000100493-26-000047.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000100493-26-000047 |

## Latest annual report

[Form 10-K for the fiscal year ended Sep 27, 2025](/filings/0000100493-25-000095.md), filed Nov 10, 2025.

## Forecast league

Q4 FY2026, the quarter ended 2026-09-27, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/1c6ff5ee-5007-432b-8c40-d52773c2e5cc)

## About the filer

- CIK: 100493
- Tickers: TSN
- Exchange: NYSE
- SIC code: 2015 Poultry Slaughtering and Processing
- State of incorporation: DE
- Filer category: Large accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:21 ET. No prices; not investment advice.